Literature DB >> 25090805

Epidemiology of ENT emergencies.

F Lammens, N Lemkens, G Laureyns, W Lemmens, L Van Camp, P Lemkens.   

Abstract

OBJECTIVE: To give an overview of ear, nose, and throat (ENT) pathologies encountered in the emergency room (ER).
METHODS: Retrospective analysis of 1296 files of patients visiting the ER between January 2008 and December 2012. Diagnosis, treatment, hospitalisation, referral, and demographic parameters were evaluated.
RESULTS: Epistaxis is the most frequent ENT condition seen in the ER. One third of epistaxis patients are on anticoagulant therapy. The second most frequent conditions observed were infections of the pharynx and tonsils. Nasal fractures and vertigo were also frequently observed.
CONCLUSION: Epistaxis and its treatment were the most frequent ENT diagnosis and therapy seen in the ER. Infections are the main cause of hospitalisation. Referral to other disciplines and revisits seldom occurred.

Entities:  

Mesh:

Year:  2014        PMID: 25090805

Source DB:  PubMed          Journal:  B-ENT        ISSN: 1781-782X            Impact factor:   0.082


  4 in total

1.  Characteristics of Otorhinolaryngological Emergencies in the Elderly.

Authors:  Sibel Yıldırım; Zahide Çiler Büyükatalay; Ahmed Majid Naji Agha Oghali; Rıdvan Kılıç; Gürsel Dursun
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-03-26

2.  Assessment of First Aid Measures to Control Epistaxis Among Health Care Providers at Tertiary Care Hospital in Saudi Arabia.

Authors:  Mazin Merdad; Saad A Sanad; Rakan H Alelyani; Abdulaziz M Alkhammash; Faisal M Swead; Oday M Alghamdi
Journal:  Cureus       Date:  2022-08-19

3.  Ten-year prevalence of acute hospital ENT infections and the impact of COVID: A large population study.

Authors:  Bassem Mettias; David Jenkins; Peter Rea
Journal:  Clin Otolaryngol       Date:  2022-09-06       Impact factor: 2.729

4.  [Epistaxis and anticoagulation therapy: an analysis based on health insurance data from Lower Saxony].

Authors:  A E Althaus; U Arendt; F Hoffmann; J Lüske; M H Freitag; K Jobski; M Dörks
Journal:  HNO       Date:  2021-03       Impact factor: 1.284

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.